Gufic BioSciences Ltd (GUFICBIO) — Announcement | 8 September 2026

8 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

CRISIL reaffirmed and upgraded Gufic BioSciences' credit ratings.

🔄 What Changed

Total bank loan facilities increased from Rs. 425 crore to Rs. 516 crore.

💡 Investor Takeaway

The rating reaffirmation signals stable credit health and supports continued access to financing.

Gufic BioSciences announced that CRISIL reaffirmed its credit ratings on bank facilities, upgrading the total loan amount from Rs. 425 crore to Rs. 516 crore while maintaining a stable long-term rating of CRISIL A- and a short-term rating of CRISIL A2+. The reaffirmation underscores continued confidence in the company's financial stability and creditworthiness.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GUFICBIO ✨ Ask AI About This

About Gufic BioSciences Ltd (GUFICBIO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,224.9 CrP/E: 57.5ROE: 11.1%ROCE: 12.9%Div Yield: 0.02%

View full GUFICBIO stock details →

📡 Get AI alerts when GUFICBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUFICBIO — Free

💡 Ask AI about this filing

"How does the upgraded loan amount affect Gufic BioSciences' leverage ratios?""What are the peer companies' credit ratings in the Indian pharma sector?""What specific actions drove the rating upgrade from Rs. 425 to Rs. 516 crores?"

Ask AI Free →

📊 More GUFICBIO filings

🔴 Announcement — 29 September 2026Gufic BioSciences announced it received an appellate order from the Commissioner of Income Tax (Appe...
🔴 Announcement — 28 September 2026Gufic BioSciences announced that Crisil ESG Ratings assigned an overall ESG rating of CRISIL ESG 62 ...
Announcement — 28 September 2026Gufic BioSciences announced that its trading window will close on October 1, 2026, and remain shut u...
🔴 Announcement — 24 September 2026Gufic BioSciences disclosed penalties of ₹8,000 and [amount not verified] imposed by BSE and NSE for...
🟡 Board Meeting — 4 September 2026Gufic Biosciences held its 42nd AGM on September 4, 2026 via video conference, approving the audited...

See all GUFICBIO filings →

🔥 Also filed on 8 September 2026

500357Rama Paper Mills LtdAnnual Report 514028Rajkamal Synthetics LtdAnnual Report INDIANORGFutura Polyesters LtdFinancial Results UYFINCORPU. Y. Fincorp LtdAnnual Report APOLLOApollo Micro Systems LtdAnnual Report 544201Dindigul Farm Product LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUFICBIO files new disclosures

Track GUFICBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.